van Ruiten CC, Veltman DJ, Schrantee A, van Bloemendaal L, et al. Effects of dapagliflozin and combination therapy with exenatide on food-cue induced brain activation in patients with type 2 diabetes. J Clin Endocrinol Metab 2022 Feb 3. pii: 6521281. doi: 10.1210.
PMID: 35134184